NCT06470698

Brief Summary

This longitudinal repeated measures study will evaluate participants at the beginning of treatment through an assessment of psychological measures and craving. They will be trained to use a mobile platform, which will be available for 12 days. The assessment will be conducted via Ecological Momentary Assessment (EMA), with scheduled daily access and during situations of consumption risk. Each access will include questions on substance use, depression, anxiety, triggering situations, attitude towards drugs, and a cognitive bias test. The platform will alternate between two tests (Drug Stroop Task and WAT-DUD). Participants will follow a treatment program supervised by professionals. The study aims to recruit 130 participants (65 for alcohol, 65 for cocaine) from the Provincial Service for Drug Dependence and Addictions in Huelva (SPDA). Participants, selected via stratified random sampling, must reside in Huelva, sign informed consent, have a compatible mobile device, and be over 18. Anonymity will be ensured through alphanumeric codes. Upon treatment admission, selected patients will be informed of their participation in the study. Interviews, conducted by psychologists, will outline the study objectives and duration. Patients agreeing to participate will sign informed consent and receive an identification code. Baseline assessment data will be integrated into a database for subsequent statistical analysis. The assessment encompasses the collection of four blocks of information: Block 1. Patients medical history initiated during treatment admission. Block 2. Neuropsychological battery developed by the research team for the baseline evaluation. Block 3. Neuropsychological battery developed by the research team for the web platform measured through Ecological Momentary Assessment (EMA). Block 4. Follow-up information at three and six months provided by SPDA professionals through the patients medical history. To ensure compliance with participant follow-up, a mixed monitoring protocol has been developed, which includes phone calls and WhatsApp messages. This protocol is designed according to social exchange theory so that participants perceive the benefits of their participation as outweighing the costs. The statistical analysis involves identifying outliers and trimming distributions. Data will be averaged per test per person, considering different conditions. Repeated measures ANOVA will analyze factors such as gender and substance type to address study objectives, examining interactions and conducting planned contrasts for specific comparisons.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 24, 2024

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

May 24, 2024

Last Update Submit

June 18, 2024

Conditions

Keywords

Ecological Momentary AssessmentSubstance Use DisorderCocaineAlcoholTreatmentGender

Outcome Measures

Primary Outcomes (4)

  • Differences between daily access scores and temptation access scores

    We may find statistically significant differences between the scores obtained during episodes of temptation to consume or purchase substances and those obtained from daily measures, with higher scores during temptation episodes. These differences will be observed in both groups, among both men and women.

    Through study completion, an average of 2 years

  • Relationship between number of episodes of temptations and scores in the tests

    It may be that during the monitoring, those participants who experience a higher number of episodes of temptation will have elevated levels in the scheduled measures. Those participants who have higher scores during episodes of temptation will have a greater number of episodes of consumption. These relationships will be observed in both groups, among both men and women.

    Through study completion, an average of 2 years

  • Differences based on the type of substance

    There may be statistically significant differences in the test scores based on the type of substance.

    Through study completion, an average of 2 years

  • Relationship between the studied variables and variables associated with gender.

    We may find differences in test scores based on gender-related variables.

    Through study completion, an average of 2 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals receiving treatment for Substance Use Disorder (SUD) at the Provincial Service for Drug Dependence and Addictions (SPDA) in the province of Huelva, Spain.

You may qualify if:

  • Patients initiating treatment for addiction to cocaine or alcohol as the primary substance.
  • Patients with a diagnosis of Substance Use Disorder of mild, moderate, or severe severity, according to the 5th Edition of the DSM (Diagnostic and Statistical Manual of Mental Disorders).
  • Maintaining residency in the province of Huelva during the study\'s follow-up period.
  • Willingness to participate in the study by providing informed consent.
  • Possessing a mobile device that meets the necessary technical requirements for the installation and operation of the application.

You may not qualify if:

  • Patients with severe, unstable mental disorders, as assessed by the clinical team at the treatment centers.
  • Patients with physical or mental disorders that hinder the execution of the tests and assessments included in the study.
  • Patients under the age of 18.
  • Patients with opioid consumption.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Huelva

Huelva, 21007, Spain

RECRUITING

MeSH Terms

Conditions

Substance-Related DisordersCoitus

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersSexual BehaviorBehavior

Study Officials

  • Enrique Moraleda-Barreno, PhD

    University of Huelva

    PRINCIPAL INVESTIGATOR
  • José A. Lorca-Marín, PhD

    University of Huelva

    PRINCIPAL INVESTIGATOR
  • Ana Segura-Barriga, Graduate

    University of Huelva

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ana Segura-Barriga, Graduate

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2024

First Posted

June 24, 2024

Study Start

July 21, 2023

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

June 24, 2024

Record last verified: 2024-06

Locations